BPC-157 + TB-500 10mg

Description

BPC-157 + TB-500 10mg is listed by Purity Collective as a lyophilized research blend for qualified laboratory procurement. This page is written to help a purchaser confirm the catalog identity, listed format, current batch documents and research-use boundary before ordering.

BPC-157 + TB-500 10mg catalog facts

• Product: BPC-157 + TB-500 10mg
• Format: Lyophilized vial
• Listed quantity: 10mg total blend, represented by the current documents as 5mg BPC-157 and 5mg TB-500
• SKU: PC-BPC-157-TB-500
• Current certificate batch: PCCL-7454331

Available documentation

The current certificate record includes two attached PDF documents. Review both files together because the identity and endotoxin information are split across separate reports.

• UPLC/MS component report for batch PCCL-7454331
• Endotoxin report for related batch PCCL-7454331-E
• How to read a peptide COA
• BPC-157 research and COA guide
• TB-500 research records and COA review guide

Document-label note: one uploaded PDF filename contains “endotoxin,” but the PDF content is a four-page UPLC/MS component report. The separate one-page PDF is the endotoxin report.

Component-specific report details

The UPLC/MS report lists a 5mg specification for each component. It reports BPC-157 at 4.90mg with 99.36% purity and TB-500 at 4.90mg with 99.19% purity. These are component-specific results for the tested sample; they should not be rewritten as one blanket blend-wide purity claim.

Endotoxin report details

The endotoxin PDF lists batch PCCL-7454331-E and reports <0.05 EU/mL. The report shows analysis conducted on April 3, 2026 and a received date of April 8, 2026, so the chronology should be read exactly as printed. The report does not print a separate acceptance specification.

Documentation scope

The current documents support a cautious component-by-component review of the listed research blend. They do not convert the product into a treatment, wellness, consumer-use or human-use product, and they should not be used to imply clinical suitability.

BPC-157 + TB-500 10mg FAQs

What is listed on this page?

This page lists a BPC-157 + TB-500 10mg lyophilized research blend from Purity Collective, with SKU PC-BPC-157-TB-500 and current batch documentation tied to PCCL-7454331.

What does the 10mg quantity mean?

The current documentation represents the blend as 5mg BPC-157 and 5mg TB-500. The product attribute should be read as 10mg total, not 10mg of each component.

Which analytical documents are available?

The listing includes a UPLC/MS component report and a separate endotoxin report. The UPLC/MS report gives component-specific quantity and purity results; the endotoxin report gives the <0.05 EU/mL result for the related endotoxin batch.

Does 99.36% describe the entire blend?

No. The 99.36% value belongs to the BPC-157 component in the UPLC/MS report. The same report lists TB-500 separately at 99.19%, so public copy should keep those values component-specific.

Is BPC-157 + TB-500 10mg intended for human use?

No. This listing is for qualified laboratory research use only. It is not offered for human or veterinary use, and no protocol, administration or outcome guidance is provided.

Research-use notice

Review the product label, batch documentation and institutional requirements before procurement. If a required certificate, specification or document field is not visible, treat that information as unverified until the current product documentation is supplied.